Gemini Therapeutics logo
Gemini Therapeutics GMTX
$ 1.56 0.97%

Gemini Therapeutics Operating Income 2011-2024 | GMTX

Annual Operating Income Gemini Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-91.1 M -47.5 M -30.9 M -34 M - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-30.9 M -91.1 M -50.9 M

Quarterly Operating Income Gemini Therapeutics

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-19 M -17.3 M -25.1 M - -10.5 M -12 M -9.96 M - -18.4 M -16.3 M -16.5 M - -7.95 M -6.67 M -9.63 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
-6.67 M -25.1 M -14.1 M